Assignee
SIGNAL PHARM INC
US·34 granted patents·8 pending applications·834 citations·filing 1992–2006
Top patents by PatentIndex Score
42 records- 0193US6897231B2Indazole derivatives as JNK inhibitors and compositions and methods related theretoSIGNAL PHARM INC·Filed 2001·Granted May 24, 2005·62 cites·26 claims
- 0293US5939421AQuinazoline analogs and related compounds and methods for treating inflammatory conditionsSIGNAL PHARM INC·Filed 1997·Granted Aug 17, 1999·57 cites·25 claims
- 0391US6331562B1Compounds and methods for modulation of estrogen receptorsSIGNAL PHARM INC·Filed 2000·Granted Dec 18, 2001·63 cites·63 claims
- 0491US6291456B1Compounds and methods for modulation of estrogen receptorsSIGNAL PHARM INC·Filed 2000·Granted Sep 18, 2001·62 cites·78 claims
- 0591US5811428APyrimidine carboxamides and related compounds and methods for treating inflammatory conditionsSIGNAL PHARM INC·Filed 1995·Granted Sep 22, 1998·69 cites·27 claims
- 0690US5935966APyrimidine carboxylates and related compounds and methods for treating inflammatory conditionsSIGNAL PHARM INC·Filed 1997·Granted Aug 10, 1999·63 cites·24 claims
- 0788US6593322B1Compounds and methods for modulation of estrogen receptorsSIGNAL PHARM INC·Filed 2000·Granted Jul 15, 2003·31 cites·26 claims
- 0887US6436923B1Compounds and methods for modulation of estrogen receptorsSIGNAL PHARM INC·Filed 2000·Granted Aug 20, 2002·26 cites·50 claims
- 0986US6620838B1Benzopyrazone compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARM INC·Filed 2002·Granted Sep 16, 2003·24 cites·33 claims
- 1083US6576437B2Stimulus-inducible protein kinase complex and methods of use thereforSIGNAL PHARM INC·Filed 2001·Granted Jun 10, 2003·13 cites·10 claims
- 1182US6686351B2Compounds and methods for modulation of estrogen receptorsSIGNAL PHARM INC·Filed 2002·Granted Feb 3, 2004·15 cites·18 claims
- 1280US6656713B2Compounds and methods for modulating activation of NF-κBSIGNAL PHARM INC·Filed 2001·Granted Dec 2, 2003·14 cites·7 claims
- 1380US6372739B1Compounds and methods for modulation of estrogen receptorsSIGNAL PHARM INC·Filed 2001·Granted Apr 16, 2002·13 cites·20 claims
- 1480US5852028APyrimidine carboxylates and related compounds and methods for treating inflammatory conditionsSIGNAL PHARM INC·Filed 1995·Granted Dec 22, 1998·29 cites·39 claims
- 1579US5830651AHuman oligodendroglial progenitor cell lineSIGNAL PHARM INC·Filed 1995·Granted Nov 3, 1998·78 cites·29 claims
- 1677US5948885AMitogen-activated protein kinase p38-2 and methods of use thereforSIGNAL PHARM INC·Filed 1996·Granted Sep 7, 1999·32 cites·1 claims
- 1772US6258579B1Stimulus-inducible protein kinase complex and methods of use thereforSIGNAL PHARM INC·Filed 1997·Granted Jul 10, 2001·28 cites·4 claims
- 1872US5932425ACompositions and methods for modulating cellular NF-κB activationSIGNAL PHARM INC·Filed 1997·Granted Aug 3, 1999·35 cites·7 claims
- 1970US6677130B1Mitogen-activated protein kinase p38-2 and methods of use thereforSIGNAL PHARM INC·Filed 2000·Granted Jan 13, 2004·2 cites·5 claims
- 2070US5972674AStimulus-inducible protein kinase complex and methods of use thereforSIGNAL PHARM INC·Filed 1996·Granted Oct 26, 1999·18 cites·2 claims
- 2166US2005255094A1Mitogen-activated protein kinase kinase MEK6 and methods of use thereforSIGNAL PHARM INC·Filed 2004·Application pending·0 cites
- 2266US2006110799A1Mitogen-activated protein kinase kinase MEK6 and methods of use thereofSIGNAL PHARM INC·Filed 2006·Application pending·0 cites
- 2364US6835567B1PNS cell lines and methods of use thereforSIGNAL PHARM INC·Filed 1998·Granted Dec 28, 2004·15 cites·31 claims
- 2464US6150372APyridopyrimidine analogs and related compounds and methods for treating inflammatory conditionsSIGNAL PHARM INC·Filed 1999·Granted Nov 21, 2000·8 cites·25 claims
- 2564US2004235112A1Mitogen-activated protein kinase kinase MEK6 and methods of use thereofSIGNAL PHARM INC·Filed 2004·Application pending·0 cites
- 2662US6225122B1Human spinal cord cell lines and methods of use thereforSIGNAL PHARM INC·Filed 1998·Granted May 1, 2001·16 cites·15 claims
- 2762US6074862AMitogen-activated protein kinase kinase MEK6 and variants thereofSIGNAL PHARM INC·Filed 1995·Granted Jun 13, 2000·17 cites·2 claims
- 2861US2003175928A1Mitogen-activated protein kinase MEK6 and methods of use thereforSIGNAL PHARM INC·Filed 2003·Application pending·0 cites
- 2960US2005124007A1Human mesencephalon cell lines and methods of use thereforSIGNAL PHARM INC·Filed 2004·Application pending·0 cites
- 3060US2005095701A1PNS cell lines and methods of use thereforSIGNAL PHARM INC·Filed 2004·Application pending·0 cites
- 3158US7202049B2Mitogen-activated protein kinase p38-2 and methods of use thereforSIGNAL PHARM INC·Filed 2002·Granted Apr 10, 2007·0 cites·6 claims
- 3254US2003054528A1Mitogen-activated protein kinase p38-2 and methods of use thereforSIGNAL PHARM INC·Filed 2002·Application pending·0 cites
- 3353US5981188AMethod for identifying agents that modulate transcription of human cytomegalovirus polymeraseSIGNAL PHARM INC·Filed 1997·Granted Nov 9, 1999·8 cites·2 claims
- 3447US5945276AReporter cell line system for detecting cytomegalovirus and identifying modulators of viral gene expressionSIGNAL PHARM INC·Filed 1996·Granted Aug 31, 1999·8 cites·8 claims
- 3547US2003119072A1Methods for modulating signal transduction mediated by TGF-beta related proteinsSIGNAL PHARM INC·Filed 2002·Application pending·0 cites
- 3643US6326480B1Antisense reporter system for assaying RNA virus replicationSIGNAL PHARM INC·Filed 1999·Granted Dec 4, 2001·7 cites·6 claims
- 3739US6444455B1Mitogen-activated protein kinase P38-2 and methods of use thereforSIGNAL PHARM INC·Filed 1999·Granted Sep 3, 2002·2 cites·11 claims
- 3837US6063578ADual reporter system and methods of use thereforSIGNAL PHARM INC·Filed 1998·Granted May 16, 2000·10 cites·40 claims
- 3934US6521601B1Method and composition for inhibition of viral replicationSIGNAL PHARM INC·Filed 1992·Granted Feb 18, 2003·6 cites·10 claims
- 4032US6413720B1Method for the affinity isolation of newly synthesized RNASIGNAL PHARM INC·Filed 1999·Granted Jul 2, 2002·2 cites·14 claims
- 4130US5910411AMethod for identifying agents that modulate transcription of human cytomegalovirus polymeraseSIGNAL PHARM INC·Filed 1996·Granted Jun 8, 1999·0 cites·8 claims
- 4228US5932618AAnti-viral agents and methods relating to the use thereofSIGNAL PHARM INC·Filed 1996·Granted Aug 3, 1999·1 cites·23 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →